The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure
Stretches of cytosine-rich DNA are capable of adopting a dynamic secondary structure, the i-motif. When within promoter regions, the i-motif has the potential to act as a molecular switch for controlling gene expression. However, i-motif structures in genomic areas of repetitive nucleotide sequences...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_024f86d45e184cf18b33c0f006865d55 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Susie L. Brown |e author |
700 | 1 | 0 | |a Samantha Kendrick |e author |
245 | 0 | 0 | |a The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure |
260 | |b MDPI AG, |c 2021-01-01T00:00:00Z. | ||
500 | |a 10.3390/ph14020096 | ||
500 | |a 1424-8247 | ||
520 | |a Stretches of cytosine-rich DNA are capable of adopting a dynamic secondary structure, the i-motif. When within promoter regions, the i-motif has the potential to act as a molecular switch for controlling gene expression. However, i-motif structures in genomic areas of repetitive nucleotide sequences may play a role in facilitating or hindering expansion of these DNA elements. Despite research on the i-motif trailing behind the complementary G-quadruplex structure, recent discoveries including the identification of a specific i-motif antibody are pushing this field forward. This perspective reviews initial and current work characterizing the i-motif and providing insight into the biological function of this DNA structure, with a focus on how the i-motif can serve as a molecular target for developing new therapeutic approaches to modulate gene expression and extension of repetitive DNA. | ||
546 | |a EN | ||
690 | |a i-motif | ||
690 | |a DNA quadruplex structures | ||
690 | |a transcription regulation | ||
690 | |a cancer therapeutics | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceuticals, Vol 14, Iss 2, p 96 (2021) | |
787 | 0 | |n https://www.mdpi.com/1424-8247/14/2/96 | |
787 | 0 | |n https://doaj.org/toc/1424-8247 | |
856 | 4 | 1 | |u https://doaj.org/article/024f86d45e184cf18b33c0f006865d55 |z Connect to this object online. |